BRUSSELS (Reuters) - Belgian pharmaceutical company Galapagos said on Monday it had discovered a possible drug to treat breast cancer and expected to start first clinical trials in humans within a year.
The company, which has a series of alliances for its pipeline of drug candidates, said in a statement that GLPG1790 had shown high activity against breast tumors that were 'triple-negative' - lacking oestrogen, progesterone or HER2 receptors.
Galapagos said the triple-negative breast cancer accounted for a fifth of breast cancers, usually affected young women, and lacked available targeted drugs.
(Reporting By Philip Blenkinsop)
Source: http://news.yahoo.com/galapagos-says-discovers-breast-cancer-drug-candidate-054830919--finance.html
padma lakshmi daughtry lakers trade ann arbor news nick young elizabeth smart south dakota state
No comments:
Post a Comment